Neurodyn is focused on developing innovative solutions for neurological conditions, particularly through its SymptomGuide™ PD platform. This tool, created in collaboration with DGI Clinical Inc., is designed to assist patients, caregivers, and healthcare professionals in systematically tracking the symptoms of Parkinson's Disease. By providing a structured environment for symptom management, SymptomGuide™ PD aims to enhance the quality of care and improve communication between patients and their healthcare teams. The beta version of this platform is accessible online, indicating Neurodyn's commitment to leveraging technology for better patient outcomes.

In addition to SymptomGuide™ PD, Neurodyn is involved in various research and development initiatives aimed at advancing treatments for neurological disorders. The company actively participates in industry events, showcasing its innovations and engaging with the broader scientific community. Through its pipeline of products and contract research services, Neurodyn seeks to contribute to the understanding and management of neurological diseases, emphasizing the importance of collaboration and research in the life sciences sector.

Canada

Neurodyn utilizes a portfolio approach to identify, validate, and develop bioactives for neuroprotection and the early treatment of neurological diseases.

Neurodyn

Company Details